An analysis on risk factors of mucormycosis in post covid-19 patients

Background: In the midst of Covid-19, mucormycosis has become a major threat with rapid increase in the number of cases. It is associated with high morbidity and mortality. Coronavirus disease (COVID-19) increases risk of secondary infections like mucormycosis. We evaluated predisposing factors, for mucormycosis among patients with COVID-19 infection. Aim of the Study: The predisposing factors of Mucormycosis in post covid-19 patients. Material & Methods: The study was in 123 patients, observational and hospital based. Results: Slight male predominance is seen (59%). The time interval between covid19 and mucormycosis was 27.7 mean days. Majority 62.6% did not have previous history of diabetes, only 37.3% had previous history of diabetes, uncontrolled in 12 cases. Denovo detected diabetes in 32.5% patients, with 17.8% presenting as DKA. Use of intravenous steroids was present in 57.7 % cases Conclusion: Moderate to severe COVID 19 cases of all age groups developed Mucormycosis without underlying diabetes and injudicious use of steroids - COVID 19, an independent risk factor. Mild cases without any risk factors developed mucormycosis.